跳至主要内容
临床试验/NCT04572399
NCT04572399已完成不适用

Respiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Pilot Study

Cedars-Sinai Medical Center2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2020年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5
试验地点
2
主要终点
Negative Change in Viral Load

研究概览

简要总结

This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.

详细描述

This is a single center, open label, pilot study. 5 adult patients, aged over 18, who are confirmed positive with SARS-CoV-2 and are newly intubed, will receive UV light treatment to reduce SARS-CoV-2 viral load.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed positive test result for SARS-CoV-2
  • Mechanically ventilated
  • Endotracheal tube inner diameter of at least 7.5 mm

排除标准

  • Unable to provide informed consent (or surrogate)
  • Enrolled in a therapeutic clinical trial for same condition that does not allow recruitment in other trials
  • Pregnant women

结局指标

主要结局

Negative Change in Viral Load

时间窗: 5 days

Change of viral load in upper airway in patients admitted to hospital for COVID-19

次要结局

  • Change in Bacterial Load(5 days)
  • Ventilated Associated Pneumonia(1 month)
  • Catheter Tip Assessment on the Last Day of Treatment(5 days)
  • Days to Extubation(1 month)
  • Days to Discharge(1 month)
  • Change in C-reactive Protein(5 days)
  • Change in the World Health Organization (WHO) Coronavirus Disease (COVID)-19 10-point Ordinal Severity Scale by 30 Days(1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

George Chaux

Medical Director, Lung Transplant Program

Cedars-Sinai Medical Center

研究点 (2)

Loading locations...

相似试验